Parallax Volatility Advisers, L.P. Uni Qure N.V. Call Options Transaction History

Parallax Volatility Advisers, L.P.

$45.1 Billion
Q2 2024

Call Options

17 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2023 Nov 14, 2023	SELL	$6.71 - $11.83 $543,510 - $958,230	-81,000 Reduced 94.85%	4,400 $29,000
Q2 2023 Aug 14, 2023	SELL	$11.12 - $22.2 $97,856 - $195,360	-8,800 Reduced 9.34%	85,400 $978,000
Q1 2023 May 15, 2023	BUY	$18.7 - $23.07 $259,930 - $320,673	13,900 Added 17.31%	94,200 $1.9 Million
Q4 2022 Feb 14, 2023	BUY	$18.12 - $27.32 $1.45 Million - $2.19 Million	80,000 Added 26666.67%	80,300 $1.82 Million
Q3 2022 Nov 14, 2022	BUY	$16.98 - $25.54 $5,094 - $7,662	300 New	300 $6,000
Q1 2022 May 16, 2022	BUY	$14.54 - $21.5 $36,350 - $53,750	2,500 New	2,500 $45,000
Q4 2021 Feb 14, 2022	SELL	$20.24 - $36.01 $3.57 Million - $6.35 Million	-176,300 Closed	0 $0
Q3 2021 Nov 15, 2021	SELL	$26.01 - $38.22 $4.55 Million - $6.69 Million	-175,000 Closed	0 $0
Q3 2021 Nov 15, 2021	BUY	$26.01 - $38.22 $4.59 Million - $6.74 Million	176,300 New	176,300 $5.64 Million
Q2 2021 Aug 16, 2021	BUY	$29.97 - $37.17 $5.24 Million - $6.5 Million	175,000 New	175,000 $5.39 Million
Q4 2020 Feb 16, 2021	SELL	$35.35 - $50.67 $530,250 - $760,050	-15,000 Closed	0 $0
Q3 2020 Nov 13, 2020	BUY	$35.98 - $47.66 $539,700 - $714,900	15,000 New	15,000 $552,000
Q2 2019 Aug 14, 2019	SELL	$52.76 - $82.19 $2.11 Million - $3.29 Million	-40,000 Closed	0 $0
Q1 2019 May 15, 2019	SELL	$27.39 - $68.41 $2.47 Million - $6.16 Million	-90,000 Reduced 69.23%	40,000 $2.39 Million
Q4 2018 Feb 14, 2019	BUY	$22.8 - $33.93 $2.28 Million - $3.39 Million	100,000 Added 333.33%	130,000 $3.75 Million
Q3 2018 Nov 14, 2018	SELL	$29.75 - $43.08 $3.57 Million - $5.17 Million	-120,000 Reduced 80.0%	30,000 $1.09 Million
Q2 2018 Aug 14, 2018	BUY	$21.96 - $39.94 $3.29 Million - $5.99 Million	150,000 New	150,000 $5.67 Million

Others Institutions Holding QURE

# of Institutions

142

Shares Held

35.3M

Call Options Held

1.54M

Put Options Held

389K

View Full List

About uniQure N.V.

Ticker QURE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,729,100
Market Cap $300M
Description
uniQure N.V., a gene therapy company, engages in the development of treatments for patients suffering from genetic and other devastating diseases. Its lead program is Etranacogene dezaparvovec (AMT-061), which is in Phase III HOPE-B pivotal trial for the treatment of hemophilia B. The company also engages in developing AMT-130, a gene therapy th...

More about QURE

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Parallax Volatility Advisers, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Parallax Volatility Advisers, L.P. with notifications on news.

Account